Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants. The Company is aimed to create a new generation of drugs with transformative efficacy and safety.
|HQ||Cambridge, MA, US||Map|
|Employees (est.) (Apr 2021)||66||(+5%)|
Pandion Therapeutics total Funding
Pandion Therapeutics latest funding size
Time since last funding
|a year ago|
Pandion Therapeutics investors
|Polaris Partners, Versant Ventures, SR One, Roche Venture Fund, Boxer Capital, OrbiMed, JDRF T1D Fund, BioInnovation, BioInnovation Capital, RA Capital, Access Biotechnology|
Pandion Therapeutics has 266 Twitter Followers. The number of followers has increased 0.8% month over month and increased 6.2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Pandion Therapeutics founded?
Pandion Therapeutics was founded in 2017.
Who are Pandion Therapeutics key executives?
Pandion Therapeutics's key executives are Alan Crane, Nancy Stagliano and Jo Viney.
How many employees does Pandion Therapeutics have?
Pandion Therapeutics has 66 employees.
Who are Pandion Therapeutics competitors?
Competitors of Pandion Therapeutics include ImCheck Therapeutics, Confo Therapeutics and Sigilon.
Where is Pandion Therapeutics headquarters?
Pandion Therapeutics headquarters is located at 610 Main St, Cambridge.
Where are Pandion Therapeutics offices?
Pandion Therapeutics has offices in Cambridge and Watertown.
How many offices does Pandion Therapeutics have?
Pandion Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies